| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apolipoproteins E | 12 | 2022 | 138 | 2.050 |
Why?
|
| Endothelial Cells | 9 | 2022 | 329 | 1.880 |
Why?
|
| Catalase | 16 | 2016 | 110 | 1.340 |
Why?
|
| Apolipoproteins B | 2 | 2022 | 18 | 1.330 |
Why?
|
| ATP-Binding Cassette Transporters | 5 | 2022 | 82 | 1.320 |
Why?
|
| Macrophages | 5 | 2016 | 529 | 1.020 |
Why?
|
| Lipoproteins, HDL | 3 | 2022 | 48 | 0.990 |
Why?
|
| Superoxide Dismutase | 15 | 2012 | 158 | 0.990 |
Why?
|
| Aorta | 17 | 2016 | 198 | 0.870 |
Why?
|
| Cholesterol | 10 | 2015 | 232 | 0.850 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2015 | 16 | 0.830 |
Why?
|
| Serine Endopeptidases | 2 | 2015 | 48 | 0.810 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2015 | 78 | 0.790 |
Why?
|
| Apolipoprotein A-I | 2 | 2022 | 24 | 0.780 |
Why?
|
| Mice | 39 | 2022 | 6644 | 0.770 |
Why?
|
| Endothelium, Vascular | 5 | 2018 | 263 | 0.710 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 386 | 0.690 |
Why?
|
| Sp1 Transcription Factor | 5 | 2012 | 46 | 0.640 |
Why?
|
| Atherosclerosis | 3 | 2015 | 169 | 0.580 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 1070 | 0.580 |
Why?
|
| Lipoproteins | 2 | 2015 | 70 | 0.560 |
Why?
|
| Receptors, LDL | 3 | 2015 | 42 | 0.560 |
Why?
|
| Up-Regulation | 6 | 2014 | 536 | 0.560 |
Why?
|
| Animals | 44 | 2022 | 16992 | 0.530 |
Why?
|
| Aortic Diseases | 2 | 2009 | 34 | 0.510 |
Why?
|
| Signal Transduction | 7 | 2015 | 2157 | 0.500 |
Why?
|
| LDL-Receptor Related Proteins | 2 | 2015 | 10 | 0.480 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2016 | 299 | 0.470 |
Why?
|
| Response Elements | 2 | 2013 | 55 | 0.430 |
Why?
|
| Mice, Transgenic | 15 | 2016 | 665 | 0.410 |
Why?
|
| Mice, Knockout | 15 | 2014 | 1035 | 0.390 |
Why?
|
| Lipoproteins, LDL | 6 | 2018 | 67 | 0.380 |
Why?
|
| Antioxidants | 8 | 2009 | 443 | 0.370 |
Why?
|
| Apolipoprotein E4 | 1 | 2012 | 67 | 0.360 |
Why?
|
| Glutathione Peroxidase | 7 | 2007 | 112 | 0.360 |
Why?
|
| Reactive Oxygen Species | 5 | 2009 | 532 | 0.320 |
Why?
|
| Cell Line | 5 | 2016 | 1410 | 0.320 |
Why?
|
| Hydrogen Peroxide | 7 | 2010 | 190 | 0.320 |
Why?
|
| Ketocholesterols | 2 | 2007 | 4 | 0.320 |
Why?
|
| Lysophosphatidylcholines | 2 | 2007 | 22 | 0.310 |
Why?
|
| Lipids | 5 | 2012 | 256 | 0.310 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2022 | 11 | 0.310 |
Why?
|
| Cells, Cultured | 11 | 2018 | 1621 | 0.290 |
Why?
|
| Foam Cells | 4 | 2012 | 16 | 0.290 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 592 | 0.280 |
Why?
|
| Arteriosclerosis | 3 | 2005 | 43 | 0.280 |
Why?
|
| Benzo(a)pyrene | 4 | 2016 | 128 | 0.270 |
Why?
|
| Receptors, Aryl Hydrocarbon | 4 | 2012 | 49 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 11 | 2016 | 1869 | 0.260 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2004 | 32 | 0.260 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2004 | 59 | 0.260 |
Why?
|
| Aging | 4 | 2004 | 783 | 0.240 |
Why?
|
| Cell Communication | 2 | 2004 | 114 | 0.240 |
Why?
|
| Cell Adhesion | 4 | 2009 | 238 | 0.230 |
Why?
|
| Oxidative Stress | 7 | 2013 | 1003 | 0.220 |
Why?
|
| Caloric Restriction | 1 | 2004 | 34 | 0.210 |
Why?
|
| Cholecystokinin | 2 | 2014 | 16 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 189 | 0.200 |
Why?
|
| Lipid Peroxidation | 4 | 2009 | 140 | 0.200 |
Why?
|
| Cell Survival | 2 | 2006 | 945 | 0.200 |
Why?
|
| Phosphorylation | 5 | 2015 | 986 | 0.200 |
Why?
|
| Leukocytes | 1 | 2003 | 80 | 0.190 |
Why?
|
| Vasoconstrictor Agents | 1 | 2003 | 39 | 0.190 |
Why?
|
| Activin Receptors | 1 | 2022 | 2 | 0.190 |
Why?
|
| Activin Receptors, Type II | 1 | 2022 | 2 | 0.190 |
Why?
|
| Caveolae | 1 | 2022 | 10 | 0.190 |
Why?
|
| Receptors, Scavenger | 1 | 2022 | 16 | 0.190 |
Why?
|
| Nitric Oxide | 2 | 2012 | 386 | 0.190 |
Why?
|
| Apolipoprotein E3 | 2 | 2012 | 12 | 0.190 |
Why?
|
| Coronary Vessels | 1 | 2022 | 92 | 0.180 |
Why?
|
| Apolipoprotein B-48 | 2 | 2013 | 7 | 0.180 |
Why?
|
| Protein Kinase C | 2 | 2012 | 124 | 0.170 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 239 | 0.170 |
Why?
|
| Humans | 14 | 2022 | 43102 | 0.160 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2012 | 92 | 0.160 |
Why?
|
| Ethanol | 2 | 2013 | 224 | 0.160 |
Why?
|
| Blotting, Western | 6 | 2012 | 883 | 0.160 |
Why?
|
| Hypercholesterolemia | 2 | 2014 | 42 | 0.160 |
Why?
|
| Running | 1 | 2019 | 13 | 0.160 |
Why?
|
| Cerebrovascular Circulation | 1 | 2019 | 70 | 0.150 |
Why?
|
| Blood Pressure | 1 | 2003 | 666 | 0.150 |
Why?
|
| Plicamycin | 3 | 2011 | 9 | 0.130 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 75 | 0.120 |
Why?
|
| Calpain | 1 | 2016 | 35 | 0.120 |
Why?
|
| Monocytes | 2 | 2009 | 277 | 0.120 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 134 | 0.120 |
Why?
|
| Heterozygote | 4 | 2013 | 110 | 0.120 |
Why?
|
| Hepatic Stellate Cells | 2 | 2013 | 7 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 704 | 0.120 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 49 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 458 | 0.110 |
Why?
|
| RNA, Messenger | 5 | 2013 | 1271 | 0.110 |
Why?
|
| Intestinal Absorption | 1 | 2014 | 22 | 0.110 |
Why?
|
| Triglycerides | 4 | 2012 | 147 | 0.100 |
Why?
|
| Models, Biological | 2 | 2019 | 712 | 0.100 |
Why?
|
| Binding Sites | 1 | 2015 | 671 | 0.100 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2013 | 3 | 0.100 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2013 | 5 | 0.100 |
Why?
|
| Hepatocytes | 1 | 2013 | 80 | 0.100 |
Why?
|
| Cholagogues and Choleretics | 1 | 2012 | 3 | 0.100 |
Why?
|
| Endocytosis | 1 | 2013 | 118 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2004 | 140 | 0.100 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 42 | 0.100 |
Why?
|
| Hypertriglyceridemia | 1 | 2012 | 16 | 0.100 |
Why?
|
| Pylorus | 1 | 2012 | 4 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2004 | 247 | 0.090 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2011 | 12 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2012 | 57 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2011 | 462 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2016 | 256 | 0.090 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2011 | 18 | 0.090 |
Why?
|
| Apoptosis | 3 | 2006 | 1568 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2012 | 1596 | 0.080 |
Why?
|
| Male | 13 | 2019 | 23409 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2013 | 273 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 213 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2003 | 166 | 0.080 |
Why?
|
| F2-Isoprostanes | 2 | 2009 | 18 | 0.080 |
Why?
|
| G1 Phase | 1 | 2009 | 31 | 0.070 |
Why?
|
| Acceleration | 1 | 1989 | 3 | 0.070 |
Why?
|
| Chemical Warfare Agents | 1 | 2009 | 14 | 0.070 |
Why?
|
| DNA Damage | 2 | 2001 | 356 | 0.070 |
Why?
|
| Lung Injury | 1 | 2009 | 18 | 0.070 |
Why?
|
| S Phase | 1 | 2009 | 36 | 0.070 |
Why?
|
| Mustard Gas | 1 | 2009 | 35 | 0.070 |
Why?
|
| Myocardial Contraction | 1 | 1989 | 46 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 83 | 0.070 |
Why?
|
| 2-Aminopurine | 1 | 2008 | 10 | 0.070 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2008 | 18 | 0.070 |
Why?
|
| Macrophages, Peritoneal | 1 | 2008 | 23 | 0.070 |
Why?
|
| Caspases | 2 | 2006 | 148 | 0.070 |
Why?
|
| Liposomes | 1 | 2009 | 132 | 0.070 |
Why?
|
| Hypertension | 2 | 2006 | 835 | 0.070 |
Why?
|
| Hydrolases | 1 | 2007 | 15 | 0.070 |
Why?
|
| Lung | 2 | 2009 | 492 | 0.070 |
Why?
|
| Heart Rate | 1 | 1989 | 266 | 0.070 |
Why?
|
| Heart | 1 | 1989 | 184 | 0.070 |
Why?
|
| Bone Substitutes | 1 | 2007 | 3 | 0.060 |
Why?
|
| Skull Fractures | 1 | 2007 | 4 | 0.060 |
Why?
|
| Bioprosthesis | 1 | 2007 | 5 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2007 | 28 | 0.060 |
Why?
|
| Lysosomes | 1 | 2007 | 86 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 148 | 0.060 |
Why?
|
| Anthozoa | 1 | 2007 | 23 | 0.060 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2006 | 10 | 0.060 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2007 | 72 | 0.060 |
Why?
|
| Cell Shape | 1 | 2006 | 42 | 0.060 |
Why?
|
| Necrosis | 1 | 2006 | 54 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2006 | 227 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 216 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 206 | 0.060 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2004 | 4 | 0.060 |
Why?
|
| Enzyme Induction | 1 | 2004 | 52 | 0.060 |
Why?
|
| Liver | 4 | 2005 | 511 | 0.060 |
Why?
|
| Free Radical Scavengers | 2 | 2009 | 64 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 296 | 0.050 |
Why?
|
| Free Radicals | 1 | 2003 | 70 | 0.050 |
Why?
|
| Calcium | 1 | 2006 | 491 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 91 | 0.050 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2016 | 52 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 223 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 241 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2003 | 97 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2019 | 141 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2003 | 102 | 0.050 |
Why?
|
| Deoxyribonuclease (Pyrimidine Dimer) | 1 | 2001 | 2 | 0.050 |
Why?
|
| Gene Expression | 3 | 2015 | 701 | 0.040 |
Why?
|
| Oxidation-Reduction | 4 | 2007 | 457 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 561 | 0.040 |
Why?
|
| Mitochondria, Heart | 1 | 2001 | 60 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 436 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2001 | 133 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 131 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 526 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 306 | 0.030 |
Why?
|
| Rabbits | 2 | 2007 | 278 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 224 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 327 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 173 | 0.030 |
Why?
|
| Gastric Mucosa | 2 | 2012 | 65 | 0.030 |
Why?
|
| DNA Repair | 1 | 1998 | 198 | 0.030 |
Why?
|
| Peroxides | 1 | 2016 | 19 | 0.030 |
Why?
|
| Xenobiotics | 1 | 2016 | 16 | 0.030 |
Why?
|
| Time Factors | 3 | 2007 | 1857 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2016 | 77 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1154 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2016 | 108 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2015 | 57 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 204 | 0.030 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 2014 | 8 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2014 | 13 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2014 | 64 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2007 | 456 | 0.030 |
Why?
|
| Chloroquine | 1 | 2013 | 19 | 0.030 |
Why?
|
| Intestines | 1 | 2014 | 71 | 0.030 |
Why?
|
| Endosomes | 1 | 2013 | 33 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 694 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 100 | 0.030 |
Why?
|
| Mutation | 2 | 2011 | 1177 | 0.020 |
Why?
|
| Superoxides | 2 | 2004 | 57 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 296 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 97 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2013 | 93 | 0.020 |
Why?
|
| Apolipoproteins | 1 | 2012 | 22 | 0.020 |
Why?
|
| Cytosol | 2 | 2004 | 97 | 0.020 |
Why?
|
| Transfection | 2 | 2008 | 532 | 0.020 |
Why?
|
| Nitrergic Neurons | 1 | 2012 | 5 | 0.020 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2012 | 8 | 0.020 |
Why?
|
| Alleles | 1 | 2013 | 352 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 36 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1124 | 0.020 |
Why?
|
| Stomach | 1 | 2012 | 50 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 95 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 48 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 147 | 0.020 |
Why?
|
| Mice, Inbred DBA | 2 | 2001 | 73 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 575 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 611 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 561 | 0.020 |
Why?
|
| Female | 5 | 2012 | 24698 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 2001 | 258 | 0.020 |
Why?
|
| Amitrole | 1 | 2009 | 3 | 0.020 |
Why?
|
| Glutathione | 2 | 2001 | 171 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2009 | 26 | 0.020 |
Why?
|
| Barbital | 1 | 1989 | 1 | 0.020 |
Why?
|
| Strophanthins | 1 | 1989 | 1 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2009 | 90 | 0.020 |
Why?
|
| Ventricular Function | 1 | 1989 | 8 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 51 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 23 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 56 | 0.020 |
Why?
|
| Furans | 1 | 2009 | 40 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2009 | 143 | 0.020 |
Why?
|
| Pressure | 1 | 1989 | 50 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 1989 | 186 | 0.020 |
Why?
|
| Myocardium | 2 | 2001 | 263 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 652 | 0.020 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 411 | 0.020 |
Why?
|
| Rats | 3 | 2001 | 3735 | 0.020 |
Why?
|
| Absorbable Implants | 1 | 2007 | 3 | 0.020 |
Why?
|
| Implants, Experimental | 1 | 2007 | 6 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2007 | 8 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2007 | 4 | 0.020 |
Why?
|
| Skull | 1 | 2007 | 28 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2007 | 57 | 0.020 |
Why?
|
| Dinoprost | 1 | 2006 | 19 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2007 | 74 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2007 | 75 | 0.020 |
Why?
|
| Diet | 2 | 2002 | 826 | 0.010 |
Why?
|
| Ataxia Telangiectasia | 1 | 2005 | 7 | 0.010 |
Why?
|
| Zinc | 1 | 2006 | 131 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 518 | 0.010 |
Why?
|
| Copper | 1 | 2006 | 134 | 0.010 |
Why?
|
| Paraquat | 1 | 2004 | 20 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2004 | 27 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 70 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2006 | 389 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 58 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 105 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 108 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 151 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 98 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 137 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 105 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2003 | 42 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 83 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 83 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 311 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 187 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1455 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2004 | 281 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 429 | 0.010 |
Why?
|
| DNA-Formamidopyrimidine Glycosylase | 1 | 2001 | 2 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2001 | 7 | 0.010 |
Why?
|
| Aconitate Hydratase | 1 | 2001 | 7 | 0.010 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2001 | 6 | 0.010 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2001 | 10 | 0.010 |
Why?
|
| Sodium Iodide | 1 | 2001 | 4 | 0.010 |
Why?
|
| Endodeoxyribonucleases | 1 | 2001 | 28 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2001 | 36 | 0.010 |
Why?
|
| Food Deprivation | 1 | 2001 | 33 | 0.010 |
Why?
|
| Oxidants | 1 | 2001 | 42 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2001 | 25 | 0.010 |
Why?
|
| Permeability | 1 | 2001 | 67 | 0.010 |
Why?
|
| Comet Assay | 1 | 2001 | 77 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 800 | 0.010 |
Why?
|
| Deoxyguanosine | 1 | 2001 | 36 | 0.010 |
Why?
|
| Energy Intake | 1 | 2002 | 164 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2001 | 110 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 240 | 0.010 |
Why?
|
| Species Specificity | 1 | 2001 | 286 | 0.010 |
Why?
|
| Food | 1 | 2001 | 103 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 523 | 0.010 |
Why?
|
| Glutathione Disulfide | 1 | 1999 | 8 | 0.010 |
Why?
|
| Pyrimidine Dimers | 1 | 1998 | 3 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1998 | 42 | 0.010 |
Why?
|
| Albumins | 1 | 1998 | 33 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 204 | 0.010 |
Why?
|
| DNA | 1 | 2001 | 592 | 0.010 |
Why?
|
| ras Proteins | 1 | 1998 | 54 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1998 | 118 | 0.010 |
Why?
|
| Cats | 1 | 1998 | 82 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 148 | 0.010 |
Why?
|
| Kidney | 1 | 1999 | 372 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 316 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1998 | 307 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 983 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 1542 | 0.010 |
Why?
|
| Middle Aged | 1 | 2006 | 12222 | 0.010 |
Why?
|
| Brain | 1 | 1999 | 1472 | 0.010 |
Why?
|
| Adult | 1 | 2006 | 13872 | 0.000 |
Why?
|